Adagio Medical Holdings closed at $0.09 on Nov 4, unchanged, 94.7% below its 52-week closing high. Volume of 155.9K shares was 0.07× its 20-day average (below normal).
Split-adjusted performance: -37.5% over one month, -91.1% over six months, -92.1% over one year.
Short interest was 133.0K shares at the Oct 15 settlement, down 89.7% from the prior report (1.0% of float, 1.0 days to cover).
No reported quarters with price history yet.
Percentile among 110 companies (100 = best)
Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.
| Company | Price | Today | 6M | Rev. growth | Net margin | P/E | Mkt cap | |
|---|---|---|---|---|---|---|---|---|
| ADGMAdagio Medical Holdings | $0.0862 | 0.00% | −91.1% | — | — | — | $2.4M | |
| IVFINVO Fertility | $2.05 | +5.67% | −71.7% | +16.7% | 40.9% | — | $2.4M | Compare |
| XAIRBeyond Air | $2.33 | +0.43% | −79.4% | +0.5% | −448.8% | — | $2.3M | Compare |
| VVOSVivos Therapeutics | $0.1112 | +1.27% | −84.6% | +34.9% | −106.4% | — | $2.2M | Compare |
| BJDXBluejay Diagnostics | $2.29 | +3.62% | −69.7% | — | — | — | $2.6M | Compare |
| NXGLNexGel | $4.01 | −10.49% | −66.6% | +27.8% | −98.6% | — | $2.0M | Compare |
| AMIXAutonomix Medical | $1.61 | −3.01% | −80.1% | — | — | — | $3.2M | Compare |
| CODXCo-Diagnostics | $0.3614 | −4.89% | — | +2.0% | −3782.4% | — | $3.2M | Compare |
| AEMDAETHLON MEDICAL | $5.75 | −0.86% | −51.7% | — | — | — | $4.1M | Compare |
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
